论文信息 - Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study. - 字舞流文

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study.

M. Dimopoulos | P. Richardson | P. Moreau | X. Leleu | H. Prince | J. Huang | J. San-Miguel | M. Cavo | A. Perrot | I. Špička | F. Schjesvold | J. Minařík | F. Dubin | K. Anderson | M. Beksaç | H. V. D. van de Velde | Laure Malinge | I. Spicka